Zacks Investment Research on MSN

MRNA stock jumps on global submissions seeking nod for flu vaccine

Moderna MRNA announced that it submitted regulatory filings seeking approval for its seasonal influenza vaccine mRNA-1010 ...
The Conversation

Is there much COVID around? Do I need the new booster shot LP.8.1?

Adrian Esterman receives funding from the NHMRC, MRFF and ARC. COVID rarely rates a mention in the news these days, yet it hasn’t gone away. SARS-CoV-2, the virus that causes COVID, is still with us.
Public Broadcasting Service (PBS)Opinion

What the overhaul of U.S. vaccine guidance means for public health

In a major departure from past practice, the CDC is scaling back the number of recommended vaccines for children. The new ...
BioProcess International

Moderna CEO addresses company future in 2025 shareholder letter

Stéphane Bancel, CEO of vaccine maker Moderna, addressed shareholders in a letter that dissected the events of 2025 while projecting a positive outlook for the company’s future in 2026 and beyond.